May 03, 2022 / 03:00PM GMT
Steve Saviuk - Valeo Pharma Inc. - CEO
It's great to be back live in front of everyone being able to talk about and inform you about Valeo Pharma. I'd like to thank Jolyon, Bryan, and the whole Bloom Burton team and -- for putting this event on. It's a great event and shining a light on the Canadian healthcare sector, which they do in a tireless fashion. We -- all the presenters, I'm sure, really appreciate that.
Valeo Pharma, we stand for innovation and innovation spark's life. I'll start -- just talking a little bit about Valeo now and you'll see the forward-looking statements and then we'll get into -- we think we have a very exciting company. We're looking at a high growth opportunity, high-revenue growth opportunities, certainly over the next five years.
We have some world-class innovative products we're launching in Canada. We're a Canadian pharma company, so we were created -- founded in 2003. We focus on innovative products, the in-licensing and acquisition of those products for the Canadian market. We're looking at commercial-stage products. So typically, post-Phase III launched
Valeo Pharma Inc at Bloom Burton & Co. Healthcare Investor Conference Transcript
May 03, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers